Merck KGaA (MKKGY) Stock Price, News & Analysis

Company Overview

Merck KGaA is a global science and technology company headquartered in Darmstadt, Germany, with origins dating back to 1668. Over its more than 350-year history, the company has expanded its footprint to serve customers in over 100 countries across the Americas, Europe, Asia-Pacific and other regions. Merck KGaA’s operations are organized into three main business sectors—Healthcare, Life Science and Performance Materials—each addressing critical needs in research, development and end-user applications.

In its Healthcare segment, Merck KGaA develops and markets prescription medicines and therapies in areas such as oncology, immunology, neurology and fertility. The company also offers a portfolio of over-the-counter products for consumer health. Its research pipeline includes small molecules, biopharmaceuticals and novel delivery systems designed to address conditions ranging from multiple sclerosis to hormone-related disorders.

Merck KGaA’s Life Science division supports academic institutions, pharmaceutical and biotechnology companies with laboratory supplies, reagents, instruments and digital solutions. Following the integration of Sigma-Aldrich, now known as MilliporeSigma in North America, the unit provides tools for gene editing, single-use bioprocessing, cell therapy manufacturing and laboratory informatics, helping to accelerate scientific discovery and the development of new therapies.

The Performance Materials arm produces specialty chemicals, functional materials and high-precision components for the electronics, automotive, cosmetics and packaging industries. Offerings range from liquid crystals and OLED materials for display technologies to pigments, advanced polymers and filtration media. Since May 2021, Merck KGaA has been led by CEO Belén Garijo, under whose leadership the company continues to pursue innovation, sustainability and strategic partnerships to strengthen its global position.

Key Stats

• Today's Range: $26.44 to $26.80
• 50-Day Range: $24.84 to $28.42
• 52-Week Range: $24.32 to $35.12
• Volume: 41,478 shs
• Average Volume: 174,985 shs
• Market Capitalization: $17.20 billion
• P/E Ratio: 11.18
• Dividend Yield: 1.24%
• Price Target: N/A
• Consensus Rating: Hold

Merck KGaA Stock Analysis - MarketRank™

Merck KGaA scored higher than 67% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Merck KGaA.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 9.63%

Earnings Growth

Earnings for Merck KGaA are expected to grow by 9.63% in the coming year, from $1.87 to $2.05 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Merck KGaA is 11.18, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 40.15.

Price to Earnings Ratio vs. Sector

The P/E ratio of Merck KGaA is 11.18, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.15.

Price to Earnings Growth Ratio

Merck KGaA has a PEG Ratio of 3.25. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Merck KGaA has a P/B Ratio of 0.53. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the outstanding shares of Merck KGaA have been sold short.

Short Interest Ratio / Days to Cover

Merck KGaA has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Merck KGaA has recently decreased by 9.87%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Merck KGaA pays a meaningful dividend of 1.28%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Merck KGaA does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Merck KGaA is 13.87%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Merck KGaA will have a dividend payout ratio of 16.10% next year. This indicates that Merck KGaA will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.01% of the outstanding shares of Merck KGaA have been sold short.

Short Interest Ratio / Days to Cover

Merck KGaA has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Merck KGaA has recently decreased by 9.87%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.7 / 5
• News Sentiment: 0.00

News Sentiment

Merck KGaA has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.50 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 19 news articles for Merck KGaA this week, compared to 4 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Merck KGaA insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 0.10% of the stock of Merck KGaA is held by institutions.

MKKGY Stock Analysis - Frequently Asked Questions

How have MKKGY shares performed this year?

Merck KGaA's stock was trading at $28.63 at the start of the year. Since then, MKKGY stock has decreased by 7.0% and is now trading at $26.6160.

How were Merck KGaA's earnings last quarter?

Merck KGaA (OTCMKTS:MKKGY) issued its earnings results on Thursday, August, 7th. The company reported $0.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.06. The business earned $6.11 billion during the quarter, compared to analysts' expectations of $5.34 billion. Merck KGaA had a net margin of 13.49% and a trailing twelve-month return on equity of 9.78%.

How do I buy shares of Merck KGaA?

Shares of MKKGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 8/07/2025
• Today: 10/21/2025
• Next Earnings (Estimated): 11/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MKKGY
• Previous Symbol: OTCMKTS:MKKGY
• CIK: N/A
• Web: www.merckgroup.com
• Phone: 496151720
• Fax: 49-61-5172-2000
• Employees: 62,557
• Year Founded: 1668

Profitability

• EPS (Trailing Twelve Months): $2.38
• Trailing P/E Ratio: 11.18
• Forward P/E Ratio: 14.23
• P/E Growth: 3.25
• Net Income: $3.00 billion
• Net Margins: 13.49%
• Pretax Margin: 17.12%
• Return on Equity: 9.78%
• Return on Assets: 5.75%

Debt

• Debt-to-Equity Ratio: 0.22
• Current Ratio: 1.24
• Quick Ratio: 0.78

Sales & Book Value

• Annual Sales: $22.57 billion
• Price / Sales: 0.76
• Cash Flow: $8.24 per share
• Price / Cash Flow: 3.23
• Book Value: $50.22 per share
• Price / Book: 0.53

Miscellaneous

• Outstanding Shares: 646,210,000
• Free Float: N/A
• Market Cap: $17.20 billion
• Optionable: Not Optionable
• Beta: 0.95